What is the official website of WuXi Chemistry ?

The official website of WuXi Chemistry is https://chemistry.wuxiapptec.com/.

What is WuXi Chemistry's cybersecurity risk score?

WuXi Chemistry has an AI-generated cybersecurity risk score of 755 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has WuXi Chemistry experienced?

According to Rankiteo, WuXi Chemistry currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has WuXi Chemistry been affected by any supply chain cyber incidents ?

According to Rankiteo, WuXi Chemistry has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does WuXi Chemistry have SOC 2 Type 1 certification ?

According to Rankiteo, WuXi Chemistry is not certified under SOC 2 Type 1.

Does WuXi Chemistry have SOC 2 Type 2 certification ?

According to Rankiteo, WuXi Chemistry does not hold a SOC 2 Type 2 certification.

Does WuXi Chemistry comply with GDPR ?

According to Rankiteo, WuXi Chemistry is not listed as GDPR compliant.

Does WuXi Chemistry have PCI DSS certification ?

According to Rankiteo, WuXi Chemistry does not currently maintain PCI DSS compliance.

Does WuXi Chemistry comply with HIPAA ?

According to Rankiteo, WuXi Chemistry is not compliant with HIPAA regulations.

Does WuXi Chemistry have ISO 27001 certification ?

According to Rankiteo,WuXi Chemistry is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does WuXi Chemistry operate in ?

WuXi Chemistry operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does WuXi Chemistry have ?

WuXi Chemistry employs approximately 426 people worldwide.

Does WuXi Chemistry own any subsidiaries ?

WuXi Chemistry presently has no subsidiaries across any sectors.

How many LinkedIn followers does WuXi Chemistry have ?

WuXi Chemistry's official LinkedIn profile has approximately 18,798 followers.

What is the NAICS classification code for WuXi Chemistry ?

WuXi Chemistry is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does WuXi Chemistry have a Crunchbase profile ?

No, WuXi Chemistry does not have a profile on Crunchbase.

Does WuXi Chemistry have a LinkedIn profile ?

Yes, WuXi Chemistry maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/wuxichemistry.

How many cybersecurity incidents has WuXi Chemistry experienced ?

As of September 30, 2026, Rankiteo reports that WuXi Chemistry has not experienced any cybersecurity incidents.

How many peer or competitor companies does WuXi Chemistry have ?

WuXi Chemistry has an estimated 5,771 peer or competitor companies worldwide.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

WuXi Chemistry

Boost Score +25 with badge (5 left)

755

/1000

Fair

780

/1000

Fair

WuXi Chemistry Vendor Cyber Rating & Cyber Score

wuxiapptec.com

Add Your Compliance Badge

WuXi Chemistry, a business division of WuXi AppTec, provides contract services for new drug development from discovery to commercial. Our unique CRDMO model offers an integrated solution combining traditional CRO (contract research organization), CDMO (contract development and manufacturing organization) and CMO (contract manufacturing organization) services under one roof. As a world leading chemistry service organization, WuXi Chemistry have over 24,000+ employees from our 16 research, development or manufacturing sites worldwide, serving over 2,000+ clients from top pharma to virtual biotech companies. Our services cover all categories for all synthetic molecular modalities, meeting any material requirement at any scale. Visit STA,

WuXi Chemistry

WuXi Chemistry CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

WuXi Chemistry Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for WuXi Chemistry

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for WuXi Chemistry in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for WuXi Chemistry in 2026.

Incident Types WuXi Chemistry vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for WuXi Chemistry in 2026.

Incident History - WuXi Chemistry (X = Date, Y = Severity)

Loading…

SUBSIDIARY

WuXi Chemistry Subsidiaries

Parent Company

WuXi Chemistry

Pharmaceutical Manufacturing

Website: https://chemistry.wuxiapptec.com/

Company Size: 426

No subsidiary data available for this company.

Loading…

WuXi Chemistry Similar Companies

MSD

msd.com

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

UCB

cb ucb.com

At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine. We are driven by the experiences of patients and caregivers, and inspired to pursue innovations that create real value - not just in clinical outcomes, but in everyday moments, dreams pursued, and simple pleasures enjoyed. Our ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives. From our headquarters in Belgium to nearly 40 countries around the world, we nurture a culture of respect and care. By listening deeply and collaborating across borders and disciplines, we enable cutting-edge research shaped by patients’ needs. Through strong connections with healthcare professionals, partners, and communities, we strive to make a lasting impact - today and into the future. We're inspired by patients, driven by science.

Cipla

cipla.com

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.

Parexel

parexel.com

Parexel is a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 24,000+ professionals worldwide work in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind — broadening access and making clinical research a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’s most complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process. Our insights-driven approach, proven delivery and trusted execution are accelerating the delivery of life-changing treatments to patients — With Heart.™ We continue to earn recognition industrywide, including the 2025 Scrip Award for “Best Contract Research Organization – Full-Service Provider,” 2024 Fierce Biotech CRO Award for "Innovative Approaches to Patient-Centric Research" and the 2024 and 2023 Society for Clinical Research Sites (SCRS) Eagle Award. Community Guidelines Because Parexel’s social media channels are open to the general public and employees, we are not responsible for views expressed other than our own. However, we do not tolerate posts that are: • Abusive, harassing or threatening to others. • Defamatory, offensive, obscene, vulgar or depicting violence. • Hateful targeting by race/ethnicity, age, color, creed, religion, gender, sexual preference or orientation, nationality or political beliefs. • Sexually explicit or pornographic. • Fraudulent, deceptive, libelous, misleading or unlawful. • Referencing criminal or illegal activity. • Spamming. We reserve the right to remove comments that do not adhere to our guidelines and report users who violate the rules of our page.

Astellas Pharma

astellas.com

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

Sanofi

sanofi.com

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

Novartis

novartis.com

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

Alembic Pharmaceuticals Limited

alembic-india.com

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara.

MENARINI Group

menarini.com

The Menarini Group is a leading international pharmaceutical and diagnostics company, with 140 years of history, present in 140 countries worldwide, with a turnover of 4.88 billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, diabetes, and anti-inflammatory/analgesics. The Group’s pharmaceutical production is carried out in its 18 manufacturing plants and is distributed across six continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world. For further information, please visit www.menarini.com For reading our Netiquette, please visit https://www.menarini.com/en-us/data-privacy/netiquette-of-menarini-group For reading our Privacy Notice for social networks users, please visit https://www.menarini.com/en-us/data-privacy/privacy-notice-for-social-network-users-of-menarini-group

Loading…

NEWS

WuXi Chemistry CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

January 03, 2025 08:00 AM

Preclinical Medical Device Testing Services Market Outlook,

Chemistry Tests Poised for Rapid Growth, Driven by Demand for Precision in Detecting Impurities...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-103047

SUMMARY

Improper neutralization of input during web page generation ('cross-site scripting') vulnerability in The Wikimedia Foundation Mediawiki - CentralAuth extension allows Stored XSS. This issue affects Mediawiki - CentralAuth extension: before 1.46.1, 1.45.5, 1.43.10.

Published

Date2026-09-29

Updated

Date2026-09-29

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2026-103046

SUMMARY

Improper neutralization of input during web page generation ('cross-site scripting') vulnerability in Wikimedia Foundation MediaWiki - WikiLambda extension allows Stored XSS. This issue affects MediaWiki - WikiLambda extension: before 1.46.1.

Published

Date2026-09-29

Updated

Date2026-09-29

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2026-103045

SUMMARY

Improper neutralization of input during web page generation ('cross-site scripting') vulnerability in The Wikimedia Foundation Mediawiki - Refreshed skin allows Stored XSS. This issue affects Mediawiki - Refreshed skin: before 1.46.1, 1.45.5, 1.43.10.

Published

Date2026-09-29

Updated

Date2026-09-29

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2026-103044

SUMMARY

XML injection (aka blind XPath injection) vulnerability in The Wikimedia Foundation Mediawiki - EasyTimeline extension allows XML Injection. This issue affects Mediawiki - EasyTimeline extension: before 1.46.1, 1.45.5, 1.43.10.

Published

Date2026-09-29

Updated

Date2026-09-29

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2026-103043

SUMMARY

anchorme through 3.0.8 contains a regular expression denial of service vulnerability in the IPv6 host extraction regex due to catastrophic backtracking. Attackers can supply specially crafted input strings with repeated patterns to cause exponential regex engine backtracking, blocking the Node.js event loop and denying service to other requests.

Published

Date2026-09-29

Updated

Date2026-09-29

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

cvss4

Base Score: 8.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

3.9

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

WuXi Chemistry Vendor Cyber Rating & Cyber Score

WuXi Chemistry A.I CyberSecurity Scoring

WuXi Chemistry CyberSecurity News & History

WuXi Chemistry Company Scoring based on AI Models